Expert: Bispecific T-cell engager targeting DLL3 on tumor cells and CD3 on T-cells, inducing T-cell mediated cytotoxicity of SCLC.
Everyday: Brings immune T-cells directly to cancer cells expressing DLL3 protein, common in small cell lung cancer.
Targets: ["DLL3"]